US approves controversial new Alzheimer’s drug

About This Source - Al Jazeera English

The video item below is a piece of English language content from Al Jazeera. Al Jazeera is a Qatari state-funded broadcaster based in Doha, Qatar, owned by the Al Jazeera Media Network.

Recent from Al Jazeera English:

  • What’s causing wildfires? | Inside Story
  • China races to curb Delta-spurred COVID outbreak, worst in months
  • Argentina declares six-month ‘water emergency’ for Parana River
  • Al Jazeera English published this video item, entitled “US approves controversial new Alzheimer’s drug” – below is their description.

    US government health regulators have approved the first medication called aducanumab to treat Alzheimer’s disease in nearly two decades.

    Its makers say it reduces fatty plaque in the brain which is the main reason for mental decline.

    But independent experts say more studies on the drug need to be done as results are so far inconclusive.

    Al Jazeera’s Rob Reynolds reports.

    – Follow us on Twitter: https://twitter.com/AJEnglish/

    – Find us on Facebook: https://www.facebook.com/aljazeera/

    – Check our website: https://www.aljazeera.com/

    #Alzheimers #Aducanumab #Biogen

    Al Jazeera English YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    Leave a Comment